免疫和构成性蛋白酶体晶体结构显示了基质和抑制剂特异性的差异
Eva M Huber1, Michael Basler, Ricarda Schwab
1Center for Integrated Protein Science at the Department Chemie, Lehrstuhl für Biochemie, Technische Universität München, Garching D-85747, Germany.
Cell
|February 21, 2012
概括
我们确定了小鼠蛋白质体和免疫蛋白质体的结构,揭示了抑制剂PR-957如何选择性地向免疫蛋白质体. 这一发现有助于设计用于癌症和自身免疫性疾病的新药.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 免疫学 免疫学 免疫学
背景情况:
- 蛋白质体对抗原呈现至关重要,存在于具有独特催化子单元的构成性和免疫蛋白质体形式.
- 这些子单元影响主要组织相容性复合物I类 (MHC-I) 分子所呈现的谱.
研究的目的:
- 阐明PR-957.7对免疫蛋白酶的选择性抑制的结构基础.
- 了解构成性蛋白质体和免疫蛋白质体之间的结构差异.
主要方法:
- 鼠标构成性蛋白质体和免疫蛋白质体 (带有或没有PR-957) 的X射线晶体学,分辨率为2.9 Å.
- 酵母蛋白酶的时间解析结构分析:PR-957复合体.
主要成果:
- 确定了免疫蛋白酶子单元β5i/LMP7的新型催化特征.
- 由于S1口袋的形状差异,PR-957选择性地与β5i亚单元结合,而不是β5c.
- 干对接特别通过反应性头组和P1侧链发生.
结论:
- 这些结构性见解支持免疫蛋白酶选择性抑制剂的合理设计.
- 这些抑制剂有潜力治疗与异常细胞因子产生相关的疾病,如癌症和自身免疫性疾病.
相关概念视频
Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome Structure
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...


